Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
doi:10.3389/fphar.2023.1327230 17
1,2 Type 1 diabetes or a history of diabetic ketoacidosis Weight-loss injections arent licensed for type 1 diabetes
CATEGORY SCOPE, DEFINITIONS AND BOUNDARIES Commercial and Technical Scope What Is Included and How the Market Is Defined Market Inclusion Criteria Product / Category Definition Exclusions and Boundaries Distinction From Adjacent Products and Substitute Categories 5
Results Patients with moderate/severe nutritional risk exhibited significantly higher hospitalization costs than those with no/mild risk, especially during the initial phases of treatment
US$ 25.85
US$ 28.43
US$ 19.99
US$ 27.50
